Submit Your Thrombosis Research to Leading Experts
Join researchers advancing our understanding of thrombotic disorders, hemostasis mechanisms, and coagulation pathophysiology through rigorous peer-reviewed publication
Why Thrombosis Researchers Choose Our Journal
The Journal of Thrombosis and Treatments provides a specialized platform for researchers investigating the molecular mechanisms of thrombotic disorders, hemostatic pathways, and coagulation cascade dysfunction. Our editorial board comprises leading experts in thrombosis pathophysiology, ensuring your research receives evaluation from peers who understand the complexities of platelet activation, endothelial dysfunction, and fibrinolytic mechanisms.
Specialized Focus: We publish cutting-edge research on thrombosis pathophysiology, including platelet biology, coagulation factor disorders, venous thromboembolism mechanisms, arterial thrombosis pathways, and novel biomarker discovery in hemostatic disorders. Our reviewers are experts in molecular mechanisms, not just clinical outcomes.
Two Convenient Submission Methods
We offer two streamlined pathways for submitting your thrombosis research. Choose the method that best fits your workflow and manuscript complexity.
ManuscriptZone Portal
Our comprehensive submission platform designed for complete manuscript management and real-time tracking throughout the peer review process.
- Auto-save functionality prevents data loss
- Guided step-by-step submission workflow
- Real-time status tracking and notifications
- Direct access to reviewer comments and decisions
- Secure document management system
- Revision submission and version control
Best for: Researchers who want complete visibility into the review process and prefer a structured submission experience with ongoing manuscript tracking.
Submit via ManuscriptZoneQuick Submission Form
A streamlined, single-page submission option for straightforward manuscripts that don't require extensive supplementary materials or complex formatting.
- No account registration required
- Simple one-page submission interface
- Fast upload for standard manuscripts
- Ideal for time-sensitive submissions
- Email confirmation upon receipt
- Transferred to ManuscriptZone for tracking
Best for: Researchers seeking the fastest submission path for standard research articles without complex supplementary files or multiple revisions anticipated.
Use Quick Submission FormArticle Types We Publish
We welcome diverse research contributions that advance understanding of thrombosis pathophysiology, hemostatic mechanisms, and coagulation disorders. Each article type undergoes rigorous peer review by experts in thrombosis research.
Original Research Articles
Novel investigations into thrombosis mechanisms, platelet activation pathways, coagulation factor function, endothelial dysfunction, or hemostatic biomarker discovery.
Mechanistic Studies
In-depth analyses of molecular mechanisms underlying thrombotic disorders, including signaling pathways, protein-protein interactions, and cellular responses in hemostasis.
Biomarker Discovery
Identification and validation of novel biomarkers for thrombotic risk assessment, disease progression monitoring, or therapeutic response prediction in coagulation disorders.
Systematic Reviews & Meta-Analyses
Comprehensive syntheses of existing research on thrombosis pathophysiology, hemostatic mechanisms, or coagulation pathway dysfunction using systematic methodologies.
Methods & Protocols
Novel experimental techniques, assay development, or methodological innovations for studying thrombosis, hemostasis, or coagulation cascade function.
Disease Models
Development and characterization of in vitro, ex vivo, or in vivo models for studying thrombotic disorders, platelet dysfunction, or coagulation abnormalities.
Short Communications
Preliminary findings, novel observations, or time-sensitive discoveries in thrombosis pathophysiology that warrant rapid dissemination to the research community.
Review Articles
Comprehensive overviews of current understanding in specific areas of thrombosis research, hemostatic mechanisms, or coagulation pathophysiology.
Perspectives & Commentaries
Expert opinions on emerging trends, controversial findings, or future directions in thrombosis pathophysiology research and hemostatic disorder investigation.
Pre-Submission Checklist
Ensure your manuscript is complete and properly formatted before submission. This checklist helps streamline the review process and prevents delays.
Reporting Guidelines: We strongly encourage adherence to discipline-specific reporting standards such as ARRIVE (animal research), CONSORT (clinical trials), STROBE (observational studies), or PRISMA (systematic reviews) to ensure methodological transparency and reproducibility.
Peer Review Timeline
We are committed to providing timely, constructive feedback while maintaining rigorous quality standards. Our transparent timeline helps you plan your research dissemination strategy.
Submission & Initial Screening
Your manuscript undergoes administrative review for completeness and adherence to submission guidelines. Plagiarism screening is performed using iThenticate software to ensure originality.
0-3 daysEditor Assignment
An Associate Editor with expertise in your specific area of thrombosis research is assigned to oversee the peer review process and make editorial decisions.
3-5 daysReviewer Selection
The assigned editor identifies and invites expert reviewers with specialized knowledge in thrombosis pathophysiology, hemostatic mechanisms, or your specific research methodology.
5-7 daysPeer Review
Expert reviewers evaluate your manuscript for scientific rigor, methodological soundness, data interpretation, and contribution to thrombosis research. Reviewers provide detailed, constructive feedback.
14-21 daysEditorial Decision
Based on reviewer recommendations, the editor makes a decision: Accept, Minor Revisions, Major Revisions, or Reject. You receive detailed feedback and specific revision requests if applicable.
21-28 days from submissionRevision Submission
If revisions are requested, you submit your revised manuscript with a detailed response to reviewer comments. We recommend addressing all reviewer concerns systematically.
Author timeline (typically 30-60 days)Re-review & Final Decision
Revised manuscripts undergo expedited re-review to verify that concerns have been adequately addressed. The editor makes a final accept/reject decision.
7-14 daysProduction & Publication
Accepted manuscripts enter production for copyediting, typesetting, and final formatting. You receive proofs for approval before online publication and indexing.
10-15 daysTotal Timeline: From submission to publication, most manuscripts complete the process within 60-90 days, depending on revision requirements. Fast-track review is available for time-sensitive discoveries in thrombosis research.
What Makes Our Review Process Rigorous
We maintain the highest standards of peer review to ensure published research advances understanding of thrombosis pathophysiology and meets the expectations of the scientific community.
Expert Reviewer Network
Our reviewers are active researchers with specialized expertise in thrombosis mechanisms, hemostatic pathways, platelet biology, coagulation disorders, and related disciplines. Each manuscript is evaluated by at least two independent reviewers with relevant methodological expertise.
Transparent Evaluation Criteria
Reviewers assess manuscripts based on:
- Scientific Rigor: Appropriate experimental design, adequate controls, statistical validity, and reproducibility
- Methodological Soundness: Proper technique application, validated assays, and appropriate model systems
- Data Quality: Clear presentation, appropriate analysis, and honest interpretation of results
- Novelty & Significance: Original contribution to thrombosis research and potential impact on the field
- Clarity & Organization: Logical structure, clear writing, and effective data visualization
Ethical Standards
As a COPE (Committee on Publication Ethics) member, we adhere to international standards for research ethics, publication integrity, and handling of misconduct allegations. All manuscripts undergo plagiarism screening, and we require appropriate ethics approvals for human and animal studies.
Constructive Feedback
Even when manuscripts are not accepted, we provide detailed, constructive feedback to help authors improve their work. Our goal is to support the advancement of thrombosis research, whether through publication in our journal or guidance for submission elsewhere.
Open Access Benefits for Thrombosis Research
Publishing open access in the Journal of Thrombosis and Treatments ensures your research reaches the widest possible audience of thrombosis researchers, clinicians, and students worldwide.
Immediate Global Visibility
Your research becomes freely accessible to readers worldwide immediately upon publication, without subscription barriers or paywalls limiting access.
- No access restrictions for readers
- Indexed in major databases ( )
- Discoverable through Google Scholar
- Increased citation potential
Accelerated Research Impact
Open access publication accelerates the pace of scientific discovery by enabling rapid dissemination and unrestricted sharing of your findings.
- Faster knowledge translation
- Enhanced collaboration opportunities
- Greater research visibility
- Broader scientific impact
Article Processing Charges (APCs): We offer competitive APCs with transparent pricing. APC waivers and discounts are available for authors from low-income countries, early-career researchers, and unfunded studies. Financial constraints should never prevent publication of high-quality thrombosis research.
Frequently Asked Questions
What is the acceptance rate for submitted manuscripts?
Our journal maintains rigorous quality standards while supporting valuable research. We do not publish a fixed acceptance rate, as decisions are based entirely on scientific merit, methodological rigor, and contribution to thrombosis research rather than arbitrary quotas.
Can I submit research that includes clinical data?
Yes, but our focus is on the pathophysiological mechanisms underlying thrombotic disorders rather than clinical management or treatment outcomes. Research that bridges mechanistic understanding with clinical observations is welcome if the emphasis is on disease mechanisms, biomarker discovery, or pathophysiological insights.
Do you accept research using animal models?
Absolutely. Animal models are essential tools for understanding thrombosis pathophysiology. We require adherence to ARRIVE guidelines for reporting animal research and appropriate ethics approvals. Studies should clearly justify the model choice and relate findings to human thrombotic disorders where applicable.
What about in vitro or cell culture studies?
In vitro studies investigating platelet function, endothelial cell biology, coagulation factor interactions, or cellular mechanisms of thrombosis are highly valued. We encourage authors to discuss the translational relevance of their findings to human thrombotic disorders.
Can I submit a systematic review or meta-analysis?
Yes, we welcome high-quality systematic reviews and meta-analyses that synthesize existing knowledge on thrombosis pathophysiology, hemostatic mechanisms, or coagulation disorders. Please follow PRISMA guidelines for reporting.
How do I know if my research is suitable for your journal?
If your research investigates the molecular mechanisms, cellular pathways, disease models, or biomarkers related to thrombotic disorders, hemostasis, or coagulation dysfunction, it is likely suitable. When in doubt, contact our editorial office for guidance before submission.
What happens if my manuscript is rejected?
Rejection decisions are based on scientific merit, not arbitrary quotas. You will receive detailed feedback explaining the decision and suggestions for improvement. Many rejected manuscripts are successfully published elsewhere after addressing reviewer concerns.
Can I suggest reviewers for my manuscript?
Yes, you may suggest potential reviewers during submission. However, the final selection of reviewers is at the editor's discretion to ensure independence and expertise. You may also identify individuals with conflicts of interest who should not review your work.
Ready to Submit Your Thrombosis Research?
Join researchers worldwide advancing our understanding of thrombotic disorders through rigorous, peer-reviewed publication. Our editorial team is here to support you throughout the submission and review process.
Start Your SubmissionNeed assistance? Contact our editorial office at [email protected]
